Thromboxane A2 Receptor Polymorphism in Association with Cerebral Infarction and its Regulation on Platelet Function

Publisher: Bentham Science Publishers

E-ISSN: 1875-5739|12|1|15-24

ISSN: 1567-2026

Source: Current Neurovascular Research, Vol.12, Iss.1, 2015-02, pp. : 15-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Binding of thromboxane A2 (TXA2) to its receptor TXA2R modulatesthrombosis/hemostasis and plays a vital role in the pathogenesis of cerebral infarction (CI). In thisstudy, we investigated the relationship between TXA2R polymorphisms and CI in Chinese Hanpopulation and the effect on platelet function by these polymorphisms. Polymerase chain reactionand ligase detection reaction (PCR-LDR) was performed in 230 CI patients and 143 healthy volunteers to examine foursingle nucleotide polymorphisms (SNPs) in human TXA2R gene (C795T, T924C and G1686A in the exon region, andrs768963 in the promoter region). We found that rs768963 polymorphism was significantly more frequent in the CI groupthan in the non-CI group and the T-T-G-T haplotype of C795T-T924C-G1686A-rs768963 was significantly less frequentin the CI subjects (0.238 versus 0.339; OR 0.617 [95%CI 0.444-0.856]). In the meantime, we constructed wild-type andmutant (C795T, G910A and T924C) eukaryotic expression plasmids, and transfected these plasmids into humanembryonic kidney (HEK) 293T cells or Chinese hamster ovary (CHO) cells stably expressing human TXA2R (GPb/a-CHO). C795T and T924C variants of TXA2R led to increased ligand binding-induced intracellular calcium influx andfibrinogen-integrin conjugation, while dominant negative mutant G910A abolished the signal enhancement. Togetherthese data show that TXA2R polymorphisms may affect platelet function and the risk of developing cerebral ischemia.

Related content